Td Waterhouse Canada Inc. Zymeworks Inc. Transaction History

Td Waterhouse Canada Inc.

  • $12.3 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Nov 13, 2023
SELL
$4.89 - $8.79 $2,303 - $4,140
-471 Closed
0 $0
Q2 2022

Nov 13, 2023
BUY
$4.82 - $7.7 $1,807 - $2,887
375 Added 390.63%
471 $3.37 Million
Q4 2021

Nov 13, 2023
BUY
$15.19 - $29.33 $1,458 - $2,815
96 New
96 $1.98 Million

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $882M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Td Waterhouse Canada Inc. Portfolio

Follow Td Waterhouse Canada Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email